Updated: May 31, 2026

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
Michael S Harris1, Jaimie L Gilbert, Kelly A Lormore
1DeVault Otologic Research Laboratory, Department of Otolaryngology-Head and Neck Surgery, Indiana, USA. michharr@iupui.edu
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Cisplatin chemotherapy can diminish cochlear implant benefits by affecting auditory nerve cells. This case highlights potential cochleotoxicity beyond the outer hair cells, impacting hearing aid effectiveness.
Area of Science:
Background:
Observation:
Findings:
Implications: